NYSE · NRC
Healthcare · Medical - Healthcare Information Services
$20.87
Down-$0.31 (-1.49%)
Updated Sep 19, 2026, 12:08 AM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 19 trading sessions · Daily adjusted prices
NRC closed at $20.87 after 19 trading sessions, down 5.95% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $22.36 | $22.36 | $20.84 | $20.87 | 88.17K |
| Sep 16, 2026 | $21.88 | $22.24 | $21.88 | $22.05 | 72.07K |
| Sep 15, 2026 | $22.31 | $22.33 | $21.90 | $21.96 | 105.03K |
| Sep 14, 2026 | $21.21 | $22.34 | $21.00 | $22.31 | 92.57K |
| Sep 11, 2026 | $21.53 | $21.53 | $20.73 | $21.12 | 94.31K |
| Sep 10, 2026 | $20.95 | $21.41 | $20.84 | $21.26 | 108.63K |
| Sep 9, 2026 | $21.08 | $21.26 | $20.75 | $20.93 | 134.69K |
| Sep 8, 2026 | $21.40 | $21.605 | $20.80 | $21.19 | 144.67K |
| Sep 4, 2026 | $20.99 | $21.67 | $20.80 | $21.53 | 141.62K |
| Sep 3, 2026 | $20.22 | $21.58 | $20.22 | $21.25 | 168.25K |
| Sep 2, 2026 | $20.47 | $20.65 | $19.925 | $20.01 | 114.05K |
| Sep 1, 2026 | $20.94 | $21.385 | $20.43 | $20.44 | 71.38K |
| Aug 31, 2026 | $21.69 | $21.69 | $20.70 | $20.94 | 96.93K |
| Aug 28, 2026 | $22.05 | $22.13 | $21.805 | $21.85 | 84.32K |
| Aug 27, 2026 | $21.83 | $22.45 | $21.35 | $22.01 | 67.8K |
| Aug 26, 2026 | $21.70 | $22.125 | $21.42 | $22.00 | 125.76K |
| Aug 25, 2026 | $21.92 | $22.1799 | $21.67 | $22.02 | 53.81K |
| Aug 24, 2026 | $22.15 | $22.5204 | $21.631 | $21.92 | 72.7K |
| Aug 21, 2026 | $21.89 | $22.50 | $21.73 | $22.19 | 339.03K |
The latest Smart Investors Daily articles mentioning NRC.
NRC research
Company profile and research snapshot.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 29, 2026 | Citizens | Market Outperform | — |
| Jun 22, 2026 | Citizens | Market Outperform | — |
No generated briefing is available yet.
Yahoo · Sep 2, 2026
LINCOLN, Neb., September 02, 2026--Healthcare leaders are under growing pressure to improve patient experience, support care teams, strengthen safety, and act on feedback faster. A new KLAS Research First Look report shows NRC Health Rounding received a 91.6 Overall Performance Score, as measured by KLAS, providing early insight into how healthcare leaders are using the solution.*
Yahoo · Sep 1, 2026
LINCOLN, Neb., September 01, 2026--NRC Health today announced the winners of its 2026 awards program, recognizing hospitals, health systems, medical groups, and specialty providers for excellence in patient experience, healthcare experience management, consumer loyalty, innovation, brand performance, and patient-centered care.
Benzinga · Aug 11, 2026
On August 7, 2026, Shane Harrison, Chief Financial Officer and principal financial officer of NRC Health, a Delaware corporation (the "Company"), tendered his resignation from the Company in order to pursue an
Yahoo · Aug 3, 2026
NRC Health's Q2 earnings per share rise year over year on higher recurring contract value and strong Governance Institute bookings, partly offset by elevated operating expenses.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning NRC.
